MedTrace Logo

Clinical Study to Evaluate Effect on QT/QTc Interval After Multiple Dose of Celecoxib

NCT03822520 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2019-01-30

No results posted yet for this study

Summary

This study is conducted to evaluate effect on QT/QTc Interval after multiple dose of celecoxib among healthy adult volunteers. It is randomized, open-label, negative and postive control, and crossover study. Volunteers will be mainly checked up through ECG to find out changes of QT/QTc interval during the study.

Conditions

  • Qt Interval, Variation in

Interventions

DRUG

Celecoxib

Celecoxib 400mg capsule

DRUG

Moxifloxacin

Moxifloxacin 400mg tablet

OTHER

Water

Pure water 150ml

Sponsors & Collaborators

  • Samsung Medical Center

    lead OTHER

Principal Investigators

  • JUNGRYUL KIM, MD, PhD · Samsung Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-06-30
Primary Completion
2018-05-25
Completion
2018-05-25

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03822520 on ClinicalTrials.gov